NDC 59667-0057

Bfing Aversion

Arnica 30c, Aurum Nat Mur 30c, Bambusa 30c, Calc Phos, Chamomilla 30c, Kali Bromatum 30c, Lilium Tig 30c, Nitricum Acidum 30c, Secale 30c, Silicea 30c, Sepia 30c, Phosphorous 30c, Platina 30

Bfing Aversion is a Oral Spray in the Human Otc Drug category. It is labeled and distributed by Home Sweet Homeopathics. The primary component is Arnica Montana; Sodium Tetrachloroaurate; Bambusa Bambos Whole; Calcium Phosphate, Dibasic, Anhydrous; Matricaria Recutita; Potassium Bromide; Lilium Lancifolium Whole Flowering; Nitric Acid; Claviceps Purpurea Sclerotium; Sepia Officinalis Juice; Silicon Dioxide; Phosphorus; Platinum.

Product ID59667-0057_447b865d-8489-4580-b712-73e016fea921
NDC59667-0057
Product TypeHuman Otc Drug
Proprietary NameBfing Aversion
Generic NameArnica 30c, Aurum Nat Mur 30c, Bambusa 30c, Calc Phos, Chamomilla 30c, Kali Bromatum 30c, Lilium Tig 30c, Nitricum Acidum 30c, Secale 30c, Silicea 30c, Sepia 30c, Phosphorous 30c, Platina 30
Dosage FormSpray
Route of AdministrationORAL
Marketing Start Date2013-08-02
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameHome Sweet Homeopathics
Substance NameARNICA MONTANA; SODIUM TETRACHLOROAURATE; BAMBUSA BAMBOS WHOLE; CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS; MATRICARIA RECUTITA; POTASSIUM BROMIDE; LILIUM LANCIFOLIUM WHOLE FLOWERING; NITRIC ACID; CLAVICEPS PURPUREA SCLEROTIUM; SEPIA OFFICINALIS JUICE; SILICON DIOXIDE; PHOSPHORUS; PLATINUM
Active Ingredient Strength30 [hp_C]/30[hp_C]; [hp_C]/30[hp_C]; [hp_C]/30[hp_C]; [hp_C]/30[hp_C]; [hp_C]/30[hp_C]; [hp_C]/30[hp_C]; [hp_C]/30[hp_C]; [hp_C]/30[hp_C]; [hp_C]/30[hp_C]; [hp_C]/30[hp_C]; [hp_C]/30[hp_C]; [hp_C]/30[hp_C]; [hp_C]/30[hp_C]
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 59667-0057-2

30 [hp_C] in 1 BOTTLE, SPRAY (59667-0057-2)
Marketing Start Date2013-08-02
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 59667-0057-2 [59667005702]

Bfing Aversion SPRAY
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2013-08-02
Inactivation Date2019-11-27

Drug Details


© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.